左氧氟沙星与氨溴索联合治疗对慢性阻塞性肺疾病合并肺部感染老年患者的疗效研究

Effect of levofloxacin combined with inhalation of large dose ambroxol injection by oxygen on levels of serum ApoE and PCT of elderly patients with COPD complicated with pulmonary infections

  • 摘要: 目的 探讨左氧氟沙星联合大剂量氨溴索注射液氧气雾化吸入对慢性阻塞性肺疾病(COPD)合并肺部感染老年患者血清载脂蛋白E(ApoE)、降钙素原(PCT)水平变化的影响。方法 选择2016年1月-2017年6月医院就诊的COPD合并肺部感染患者86例作为研究对象,将其分为A(n=29)、B(n=29)、C(n=28)三组,A组给予左氧氟沙星联合30mg盐酸氨溴索静脉滴注,B组给予左氧氟沙星联合30mg盐酸氨溴索氧气雾化吸入,C组给予60mg盐酸氨溴索氧气雾化吸入,比较三组患者临床指标。结果 3组治疗前WBC、PCT、hs-CRP、ApoE水平比较差异无统计学意义(P>0.05);B组治疗后WBC、PCT、hs-CRP、ApoE低于A组(P<0.05),C组治疗后WBC、PCT、hs-CRP、ApoE与A组和B组比较均降低(P<0.05);B组X线肺部感染病灶吸收时间和住院时间与A组比较降低;C组X线肺部感染病灶吸收时间和住院时间与A组和B组比较均降低;B组不良反应发生率高于A组,C组不良反应发生率高于A组和B组(P<0.05)。结论 左氧氟沙星联合大剂量盐酸氨溴索氧气雾化吸入治疗COPD协助控制炎症反应、提高临床疗效。

     

    Abstract: OBJECTIVE To study the effect of levofloxacin combined with inhalation of large dose ambroxol injection by oxygen on levels of serum Apolipoprotein E(ApoE) and procalcitonin(PCT) of elderly patients with chronic obstructive pulmonary disease (COPD) complicated with pulmonary infections.METHODS 86 elder patients with COPD complicated with pulmonary infections in our hospital from January 2016 to June 2017 were selected as the subjects. The patients were randomly divided into the group A(n=29 cases), group B(n=29 cases) and group C(n=28 cases). The group A was treated with levofloxacin combined with ambroxol hydrochloride intravenous drip, the group B was treated with levofloxacin combined with ambroxol hydrochloride 30mg oxygen inhalation, and the group C was treated with levofloxacin combined with ambroxol hydrochloride 60mg oxygen inhalation, then the clinical indexes were compared.RESULTS There were no significant differences in WBC, PCT, hs-CRP and ApoE among the three groups before the treatment (P>0.05). The WBC, PCT, hs-CRP and ApoE of the group B after the treatment were significantly lower than those of the group A, and the WBC, PCT, hs-CRP and ApoE of the group C after the treatment were significantly lower than those of the group A and group B(P<0.05). The absorption time of lung infection focus and hospital stay of the group B were significantly lower than those of the group A, and the absorption time of lung infection focus and hospital stay of the group C wereHT5"SSsignificantly lower than those of the group A and group B(P<0.05). The incidence of adverse reaction of the group B was significantly higher than those of the group A, and the incidence of adverse reaction of the group C was significantly higher than those of the group A and the group B(P<0.05).CONCLUSION Levofloxacin combined with high-dose ambroxol hydrochloride aerosol inhalation in the treatment of COPD to help control inflammatory response and improve clinical efficacy.

     

/

返回文章
返回